XML 44 R33.htm IDEA: XBRL DOCUMENT v3.22.1
Convertible Debt Agreement - Additional Information (Details)
3 Months Ended
Sep. 29, 2020
USD ($)
TradingDay
Installment
Facility
$ / shares
Mar. 31, 2022
USD ($)
shares
Dec. 31, 2020
USD ($)
Dec. 31, 2021
USD ($)
shares
Debt Instrument [Line Items]        
Shares of common stock reserved for future issuances | shares   23,905,040   21,805,776
Common Stock Issuable Upon Conversion of Outstanding Debt        
Debt Instrument [Line Items]        
Shares of common stock reserved for future issuances | shares   1,219,512   2,439,024
Loan and Security Agreement        
Debt Instrument [Line Items]        
Debt instrument, terms of conversion description   The Company has the right to convert at any time any portion of the then outstanding borrowings and all accrued but unpaid interest into shares of the Company’s common stock, at the applicable conversion price, subject to the fulfillment of both of the following conditions: (i) during a period of 30 consecutive trading days prior to the date on which the Company provides notice of the exercise of its conversion right, the closing price of the Company’s common stock was higher than 1.4 times the applicable conversion price of the term loans on at least 20 trading days, including on the trading day preceding the date on which the Company provides notice of the exercise of its conversion right, (ii) the number of shares of common stock issuable upon conversion by the Company shall not exceed the average weekly number of shares of the Company’s common stock traded on the stock market for the four weeks immediately preceding the date on which the Company provides notice of the exercise of its conversion right.    
Debt instrument conversion threshold consecutive trading days | TradingDay 30      
Loan and Security Agreement | Minimum        
Debt Instrument [Line Items]        
Debt instrument conversion threshold trading days | TradingDay 20      
Loan and Security Agreement | Pontifax        
Debt Instrument [Line Items]        
Loan agreement, maximum borrowing capacity $ 25,000,000.0      
Number of term loan facilities | Facility 3      
Fixed interest rate on loan amounts outstanding 9.00%      
Loan and security agreement, term 48 months      
Loan and security agreement, interest only payment period 24 months      
Expiration of interest only period Sep. 29, 2022      
Loan and security agreement, number of quarterly payments | Installment 8      
Loan and security agreement, frequency of payments   quarterly    
Conversion price for borrowings outstanding | $ / shares $ 4.10      
Debt instrument, terms of conversion description   Pontifax, at its option, has the right to convert at any time any portion of the then outstanding borrowings and all accrued but unpaid interest into shares of the Company’s common stock, at the applicable conversion price. The conversion price for borrowings outstanding under the Pontifax Agreement is fixed at $4.10 per share. If the Company consummates a stock split, stock combination, reclassification, payment of stock dividend, recapitalization or other similar transaction (each a “Stock Event”), then the applicable conversion price will be proportionately increased or decreased as necessary to reflect the proportionate change in shares of the Company’s common stock issued and outstanding as a result of such Stock Event.    
Voluntary principal repayments   $ 5,000,000.0    
Outstanding principal balance   $ 5,000,000.0   $ 10,000,000.0
Loan and Security Agreement | Pontifax | Initial Loan        
Debt Instrument [Line Items]        
Loan agreement, advanced amount $ 10,000,000.0      
Loan and Security Agreement | Pontifax | Credit Line        
Debt Instrument [Line Items]        
Loan agreement, remaining borrowing capacity $ 5,000,000.0      
Loan and security agreement, percentage fee paid 1.00%      
Unused credit facility expiration date Sep. 29, 2021      
Loan and Security Agreement | Pontifax | Third Installment Loan        
Debt Instrument [Line Items]        
Loan and security agreement, available borrowing capacity subject to achievement of milestones $ 10,000,000.0   $ 10,000,000  
Non-contingent, non-refundable gross proceeds from one or more equity financings and/or strategic partnerships $ 15,000,000.0   $ 15,000,000  
Unused credit facility expiration date Dec. 29, 2021